INTRODUCTION: Cardiac progenitor cells are multipotent, and lineage analyses of murine and chick cardiac development have demonstrated that these cells give rise to the cardiac endothelium, smooth muscle, and cardiomyocytes. However, the mechanisms governing commitment to the myocyte lineage in vivo remain largely unknown. Further understanding of these mechanisms, and of the identity of progenitors committed to the myocyte lineage, may advance cardiac regenerative therapies. 
L
ineage analyses during cardiac development in the chick and mouse over the past two decades have demonstrated that at least two pools of progenitor cells contribute to the heart (1). Cardiac progenitor cells (CPCs) derived from the cardiac crescent, or the first heart field (FHF), express Nkx2-5 and contribute to a primitive heart tube. After subsequent looping of the heart tube, additional progenitor cells are added to the arterial and venous poles of the heart from the second heart field (SHF). SHF cells arise just medial and posterior to the FHF in the cardiac crescent and populate the pharyngeal arches and dorsomedial mesoderm before migration into the heart proper (2, 3).
Studies modeling cardiac development using differentiation of embryonic stem (ES) cell-derived embryoid bodies (EBs) have demonstrated that SHF progenitors, marked by Islet1 (Isl1) expression (4) , are multipotent, with potential for differentiation into cardiomyocyte, endothelial, or smooth muscle lineages (5-7). Wnt signaling is necessary to promote and expand multipotent CPCs (8) (9) (10) , and subsequent differentiation of cardiac myocytes is influenced by bone morphogenetic protein (Bmp) signaling and Wnt inhibition (11, 12) . However, the implications of these studies for in vivo cardiogenesis are unknown. The characteristics of an embryonic CPC niche are poorly described, and the degree to which CPCs remain uncommitted during mid-and late gestation has been unclear. For example, recent reports using inducible lineage tracing of early cardiac progenitors, marked by Mesp1 expression, suggest the existence of a relatively small pool of multipotent progenitors in vivo and that at least some of these become committed at very early stages, perhaps soon after gastrulation (13, 14) . Efforts to fully characterize the signaling pathways active during cell fate decisions in vivo have been hampered, at least in part, by the lack of specific markers of lineage commitment.
Here, we report that CPCs committed to the myocyte lineage can be prospectively identified before the expression of sarcomere genes on the basis of Hopx expression, an atypical homeodomain protein expressed during early cardiac development and in multiple stem cell populations (15) (16) (17) (18) (19) . Akin to an erythroblast in hematopoietic differentiation, we have termed these committed CPCs "cardiomyoblasts." We show that SHFderived cardiomyoblasts are specified in the distal outflow tract (OFT) within a zone of high Bmp and low Wnt signaling. Finally, we show that Hopx not only marks commitment, but that it also promotes myogenesis by interacting with an activatedSmad complex to repress Wnt.
Cardiomyoblasts are defined by Hopx expression
At early stages of cardiac development, Nkx2-5 and Isl1 mark populations of CPCs (2, 4) , and Hopx expression initiates shortly after Nkx2-5 in precardiac mesoderm (15) . We used a knock-in allele in which Hopx is epitope tagged and green fluorescent protein (GFP) is expressed in Hopx + cells (18) to determine that Hopx is expressed in a subset of CPCs at embryonic day 8.0 (E8.0) and E8.5 in the FHF and SHF, respectively (Fig. 1, A and B). As SHF progenitors enter the distal OFT, Isl1 expression is gradually extinguished and Hopx expression initiates, providing a restricted region of coexpression in the distal OFT (Fig. 1B) . Fate mapping using Nkx2-5
Cre/+ and cre-dependent reporter mice indicates that essentially the entire late-gestation heart derives from Nkx2-5 + precursors, including myocytes, smooth muscle, endothelium, and epicardium (Fig. 1C) . Isl1 + cells also give rise to smooth muscle, endothelium, myocytes, and epicardium, but some of the left ventricle myocardium and atria, derived from the FHF, is not labeled in Isl1 fate-mapping experiments (Fig. 1D) . Lineage-tracing experiments using a Hopx Cre/+ allele, in which we inserted cre following an internal ribosomal entry sequence (IRES) so as to avoid perturbing Hopx expression (20), demonstrate labeling in all four cardiac chambers ( Fig. 1E and fig. S1 , A and B). However, in contrast to Nkx2-5 and Isl1, Hopx derivatives within the heart are entirely restricted to cardiac myocytes ( Fig. 1E and fig. S2 S6 ). In addition, inducing cre recombinase activity with a single dose of tamoxifen at E8.25, a time point correlating with Hopx expression within a subset of Nkx2-5 + progenitors, demonstrates lineage-labeled myocytes primarily in the left ventricle and both atria at E18.5 ( Fig. 2C) . However, similar lineage tracing of E9.25 Hopx + cells demonstrates that cardiomyoblasts expressing Hopx at this later time point contribute to myocytes in both ventricles and both atria (Fig. 2D ). Taken together, these results establish that cardiac Hopx expression identifies a pool of progenitors committed entirely to the myocyte lineage (e.g., cardiomyoblasts) and that Hopx + cardiomyoblasts expand during cardiogenesis. In addition, our results suggest that commitment of FHF and 
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SHF CPCs occurs at distinct time points during cardiogenesis.
Hopx promotes myogenesis by inhibiting Wnt signaling
Hopx is expressed early during cardiomyocyte differentiation and precedes that of troponin T (Tnnt2) in both the FHF and SHF (Fig. 3, A (Fig. 4A ). When Hopx is induced only 1 day later, at day 5, no statistically significant increase in cardiomyogenesis is observed (Fig. 4A) .
We (Fig. 4B) . Gene Ontology analysis of the top 3000 genes that are down-regulated confirmed enrichment for families of genes related to heart development and myogenesis (Fig. 4C) . Although sarcomere genes are expressed in Hopx −/− hearts, the onset of Tnnt2 expression is delayed in SHF myoblasts as they enter the OFT, as evidenced by a lack of Tnnt2 expression in Nkx2-5 + precursors within the distal OFT of Hopx −/− versus Hopx +/+ hearts at E9.5 (Fig. 4D) . The eventual expression of sarcomere genes in Hopx mutants suggests that redundant pathways exist for activation of the myogenic program.
To further define the role of Hopx during myogenesis, we defined the genomic regions occupied by Hopx by performing chromatin immunoprecipitation followed by massively paralleled sequencing (ChIP-seq). Although Hopx does not bind to DNA directly (22) , it can interact with corepressor complexes to inhibit gene expression. We performed ChIP-seq analysis of pooled chromatin derived from~35 E9.5 microdissected murine embryonic hearts (table S2). KEGG analysis of the genes associated with the strongest 3000 peaks suggested that Hopx occupancy was enriched in genomic regions proximal to Wnt family member genes (P = 3.9 × 10 −4 ), and the Wnt signaling pathway was the top hit with PANTHER analysis (P = 1.2 × 10
−3
). We independently validated Hopx occupancy close to several Wnt ligand transcriptional start sites by ChIP-QPCR (quantitative polymerase chain reaction) (Fig. 5A) . Consistent with the known function of Hopx as a transcriptional repressor (15) (Fig. 5B ). Axin2 and Isl1, both target genes of canonical Wnt signaling (23, 24) , are expressed at significantly higher levels in E9.5 Hopx −/− hearts, as compared to littermate controls (Fig. 5C ). Immunohistochemistry of E9.5 to E10.5 control OFTs reveals that the distal OFT is a transition zone in which Axin2 and Isl1 expression diminish while Hopx expression is activated (Fig. 5D ). In Hopx 
). EBs lacking
Hopx show an increase in Axin2 and significant impairment of sarcomere gene expression at day 8 of differentiation ( Fig. 5F) Actn2, Actc1). Taken together, these data suggest that Hopx repression of Wnt signaling promotes cardiomyogenesis.
Hopx interacts with Smad4
We purified Hopx-containing protein complexes from E9.5 Hopx 3XFlag/+ murine hearts and identified protein components by mass spectrometry. Numerous members of the Mi-2/NuRD (nucleosome remodeling deacetylase) complex were identified (e.g., Hdac1, Hdac2, Rbbp4/7, MTA 1/2/3, and MBD3), consistent with the known association of Hopx with Hdac2 (22) . In addition, Smad4 was identified as a Hopx-interacting protein. This finding is of particular interest because Bmp4, phospho-Smad1/5/8, and, to a lesser extent, Bmp2 are expressed in the OFT at E9.5, as we confirmed (Fig. 6A and fig. S8A ). We confirmed the interaction between Hopx and Smad4 by coimmunoprecipitation of both factors overexpressed in 293Tx cells in the presence of increasing concentrations of recombinant Bmp4 and performing coimmunoprecipitation experiments. An interaction between Hopx and Smad4 that is dependent upon the presence of Bmp4 is detectable (Fig. 6B) . Further, we confirmed that endogenous Hopx interacts with an activated Smad complex (Smad4 and phospho-Smad1/5/8) in coimmunoprecipitation experiments from E9.5 to E10 whole-embryo lysates (Fig. 6C and fig. S8B ).
We have previously determined the structure of Hopx by nuclear magnetic resonance (NMR) spectroscopy, demonstrating a helix-turn-helix motif (22) . Residues within the first and second a helix that are located close to one another were shown to be important for Hopx-mediated transcriptional repression, as were a distinct cluster of residues at the C terminus (shown in green, Fig. 6D ). We mutated amino acids in the first and second helix and at the C terminus and assayed whether the mutants could interact with Smad4 using an in situ proximity ligation assay (Fig. 6, E to I). We confirmed expression of Hopx constructs ( fig. S8, C and D) and specificity of the proximity ligation assay (fig. S8E) . Consistent with the coimmunoprecipitation experiments (Fig. 6B) , the Smad4 interaction with Hopx is enhanced by Bmp4 (Fig. 6, E and F) . The Smad4-Hopx interaction is diminished by mutation of residues at the C terminus of Hopx, but not by mutations in helix 1 or 2 (Fig. 6, G to I) . Consistent with a physical interaction between Hopx and Smad4, we detect enrichment of Smad4 occupancy by ChIP at Wnt ligand loci that are also occupied by Hopx (fig. S8F ).
Hopx integrates Bmp and Wnt signaling
The data presented thus far indicate that Hopx expression defines a cardiomyoblast and that Hopx modulates cardiomyogenesis by repressing Wnt signaling. Further, Hopx can interact with an activated Smad complex. In murine EBs, myogenesis requires inhibition of Wnt and is promoted by activation of Bmp (9, 11, (25) (26) (27) . Hence, we (Fig. 7A) . Once in the nucleus, the active Smad complex functions to enhance transcription of Bmp target genes such as Msx1. Control (wild-type) E9.5 cardiac explants respond to exogenous Bmp4 by up-regulating Msx1 in a dose-dependent fashion (Fig. 7B) . A similar response is seen in Hopx −/− explants, indicating an intact Bmp response system (Fig. 7B) .
Bmp signaling can result in repression of Wnt activity in various tissues, although the mechanism has been unclear (28) (29) (30) (31) . Addition of recombinant Bmp4 decreases Axin2 expression in Hopx +/+ cardiac explants compared to vehicle-treated controls (Fig. 7C, white bars) . However, Axin2 expression in Hopx −/− explants is relatively unresponsive to Bmp4 (Fig. 7C, black bars) . We also tested whether Hopx participates in Bmp-mediated Wnt inhibition during cardiac differentiation of EBs (Fig. 7D ). Bmp4 treatment of Hopx +/− EBs starting at day 5 results in a 60% decrease in Axin2 by day 10 of differentiation compared to vehicle-treated EBs (white bars, Fig. 7D ). However, Bmp4 minimally affects Axin2 expression in Hopx −/− EBs (black bars, Fig. 7D ). These data suggest that Hopx is required for Bmp-mediated repression of Wnt signaling during cardiogenesis. a definitive marker of a cardiomyoblast has hampered a detailed analysis of cardiomyocyte commitment. Our studies provide such a marker and reveal that commitment of FHF and SHF CPCs occurs at distinct time points and in different locations during cardiogenesis. In the SHF, Isl1 + , Wnt-activated CPCs stream into the OFT from the surrounding mesoderm, where they encounter local Bmp4 signals. CPCs then express Hopx, downregulate Wnt, and become committed to the myocyte fate. Thus, the distal OFT is a "zone of commitment" in the developing heart (Fig. 7E) .
Markers of lineage commitment, and the signals that modulate lineage decisions, are likely to inform regenerative and stem cell approaches for cardiac disease. In the hematopoietic system, detailed understanding of these processes has allowed for definitive identification of various progenitor cells of the blood lineages, leading to the development of important therapies for human diseases (e.g., erythropoietin and granulocytemacrophage colony-stimulating factor). The ability to identify committed, but undifferentiated, cardiomyocyte precursors may facilitate development of cardiac regenerative therapies, including those using ES and induced pluripotent stem cells (34) .
Reciprocal signaling between Bmp and Wnt has been recognized in multiple progenitor populations (28) (29) (30) (31) 35) . However, the mechanisms that coordinate these pathways in progenitor cell niches have remained elusive. Our current work raises the possibility that Hopx-mediated integration of Bmp signaling to repress Wnt may be active in other progenitor populations. For example, Hopx is expressed by +4 stem cells in the intestine (19) , where niche Bmp signals repress Wnt (28, 36) . Recent work by the Fuchs laboratory also suggests that balance between Bmp and Wnt signaling influences the fate of hair follicle cells as they differentiate into various progeny lineages (35) and Hopx may play a role in this process (18) . HOPX is a tumor suppressor gene implicated in colorectal and other cancers (37, 38) . Hijacking of developmental pathways is emerging as a potent mechanism of carcinogenesis (39) . Loss of Hopx in cancer stem cells could result in uncoupling of niche-mediated Bmp signaling and quiescence through loss of Wnt repression.
Finally, although Hopx deficiency leads to thinned myocardium and cardiac rupture in a portion of embryos, cardiomyogenesis is not altogether blocked. Inhibition of Wnt signaling in SHF cardiomyoblasts is delayed but not completely prevented, and some Hopx −/− mice live to adulthood. This suggests that, not surprisingly, alternative mechanisms reinforce Wnt repression independent of Hopx (40) . Further insights into the mechanisms that coordinate signaling in the niche are likely to inform our ability to harness the potential of regenerative medicine.
